Haijian Zhang

Nantong, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Histone acetylation modification regulator-mediated tumor microenvironment infiltration characteristics and prognostic model of lung adenocarcinoma patients.

Histone acetylation modification regulator-mediated tumor microenvironment infiltration characteristics and prognostic model of lung adenocarcinoma patients.

Journal: Journal of thoracic disease
Published: July 18, 2022

PRKCB is relevant to prognosis of lung adenocarcinoma through methylation and immune infiltration.

PRKCB is relevant to prognosis of lung adenocarcinoma through methylation and immune infiltration.

Journal: Thoracic cancer
Published: March 27, 2022

Immune inactivation by APOBEC3B enrichment predicts response to chemotherapy and survival in gastric cancer.

Immune inactivation by APOBEC3B enrichment predicts response to chemotherapy and survival in gastric cancer.

Journal: Oncoimmunology
Published: September 23, 2021

LncRNA NORAD regulates scar hypertrophy via miRNA-26a mediating the regulation of TGFβR1/2.

LncRNA NORAD regulates scar hypertrophy via miRNA-26a mediating the regulation of TGFβR1/2.

Journal: Advances in clinical and experimental medicine : official organ Wroclaw Medical University
Published: April 15, 2021

Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment.

Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment.

Journal: BMC cancer
Published: March 27, 2021

Extrachromosomal circular DNA: a new potential role in cancer progression.

Extrachromosomal circular DNA: a new potential role in cancer progression.

Journal: Journal of translational medicine
Published: February 18, 2021

Low expression of IL6R predicts poor prognosis for lung adenocarcinoma.

Low expression of IL6R predicts poor prognosis for lung adenocarcinoma.

Journal: Annals of translational medicine
Published: January 04, 2021

Loss of IL-34 Expression Indicates Poor Prognosis in Patients With Lung Adenocarcinoma.

Loss of IL-34 Expression Indicates Poor Prognosis in Patients With Lung Adenocarcinoma.

Journal: Frontiers in oncology
Published: December 09, 2020

A robust signature associated with patient prognosis and tumor immune microenvironment based on immune-related genes in lung squamous cell carcinoma.

A robust signature associated with patient prognosis and tumor immune microenvironment based on immune-related genes in lung squamous cell carcinoma.

Journal: International immunopharmacology
Published: April 19, 2020

High expression of interleukin-enhancer binding factor 3 predicts poor prognosis in patients with lung adenocarcinoma.

High expression of interleukin-enhancer binding factor 3 predicts poor prognosis in patients with lung adenocarcinoma.

Journal: Oncology letters
Published: February 26, 2019

Beta-1,4-galactosyltransferase II predicts poor prognosis of patients with non-metastatic clear-cell renal cell carcinoma.

Beta-1,4-galactosyltransferase II predicts poor prognosis of patients with non-metastatic clear-cell renal cell carcinoma.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: February 25, 2017

High mucin 5AC expression predicts adverse postoperative recurrence and survival of patients with clear-cell renal cell carcinoma.

High mucin 5AC expression predicts adverse postoperative recurrence and survival of patients with clear-cell renal cell carcinoma.

Journal: Oncotarget
Published: December 21, 2016
Showing 1-12 of 12

Last Updated: 09/26/2026